Heart Failure Archives - Medical Conferences

Meet the Expert: Dr Abdullahi Mohamed on Iron Deficiency in Patients with HF

Expert

Dr Abdullahi Mohamed, Herlev-Gentofte Hospital, Denmark

Conference

ESC 2024

9 September 2024 10:40

RESHAPE-HF2: Not a “tie-breaker” about TEER in heart failure

Presented By

Prof. Stefan Anker, Charité Universitätsmedizin, Germany

Trial

RESHAPE-HF2

Conference

ESC 2024

Type

News article

4 September 2024 10:43

MRAs show varied efficacy in heart failure across ejection fractions

Presented By

Prof. Pardeep Jhund, University of Glasgow, Scotland

Trial

RALES, EMPHASIS-HF, TOPCAT, FINEARTS-HF

Conference

ESC 2024

Type

News article

4 September 2024 10:35

Effects of semaglutide on MACE irrespective of HF status

Presented By

Prof. John Deanfield, University College London, UK

Trial

SELECT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:15

SEQUOIA-HCM: Aficamten demonstrates clinical efficacy in obstructive HCM

Presented By

Dr Martin Maron, Lahey Hospital and Medical Center, USA

Trial

SEQUOIA-HCM

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:13

ARIES-HM3 trial: Subgroup analysis in patients with prior need for aspirin

Presented By

Prof. Finn Gustafsson, University of Copenhagen, Denmark

Trial

ARIES HM3

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:09

Three diuretic regimens compared in the DEA-HF study

Presented By

Dr Aharon Abbo, Rambam Medical Center, Israel

Trial

DEA-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:07

Adding a mineralocorticoid receptor modulator in heart failure with CKD

Presented By

Prof. Carolyn Lam, Duke-National University, Singapore

Trial

Phase 2, MIRACLE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 17:04

Empagliflozin did not reduce mortality for HF after MI regardless of T2D status

Presented By

Prof. Javed Butler, University of Mississippi, USA

Trial

EMPACT-MI

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:49

SGLT2 inhibitors decrease atrial fibrillation risk in patients with HFrEF

Presented By

Dr Joel Manuel Alejandro, University of Maryland, USA

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:45

SGLT2 inhibition: Major and early impact on heart failure hospitalisation risk

Presented By

Dr Muthiah Vaduganathan, Brigham and Women's Hospital, USA

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:42

Individualised diuretic titration in acute HF without a physician

Presented By

Dr Evelyne Meekers, Hospital Oost-Limburg, Belgium

Trial

EASY-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:36

Intravenous iron deficiency treatment improves exercise capacity in patients with HFpEF

Presented By

Prof. Stephan von Haehling, University Medical Centre of Göttingen, Germany

Trial

Phase 2, FAIR-HFpEF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:33

CD34+ stem cells promote reverse cardiac remodelling after acute MI

Presented By

Prof. Faiez Zannad, University of Lorraine, France

Trial

Phase 1/2, EXCELLENT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:30

Sex-specific outcomes and resource utilisation after HF hospitalisation

Presented By

Dr Tauben Averbuch, University of Calgary, Canada

Trial

PACT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:27

Application of guideline-directed medical therapy in patients with HFrEF in the Netherlands

Presented By

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

TITRATE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:17

PAP-guided management system appears safe in patients with HF

Presented By

Dr Michael Kiernan, Tufts University School of Medicine, USA

Trial

PROACTIVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:12

Delivery of CRT guided by non-invasive anatomy assessment

Presented By

Dr Mikhail Chmelevsky, Cardiocentro Ticino Institute, Switzerland

Trial

CRT-DRIVE

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 16:03

RELIEVE-ing HFrEF with interatrial shunting

Presented By

Prof. Stefan Anker, Charité - University Hospital Berlin, Germany

Trial

RELIEVE-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:57

Algorithm-based remote patient monitoring was associated with lower mortality in a retrospective cohort study

Presented By

Prof. Nicolas Girerd, University Hospital of Nancy, France

Trial

TELESAT

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:46

High mortality and morbidity in suspected de novo HF in outpatient care

Presented By

Dr Lisa Anderson, St George’s Healthcare NHS Foundation Trust, UK

Trial

REVOLUTION-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:44

Bio-ADM as a marker for congestion in patients hospitalised for acute HF

Presented By

Mr Geert Voordes, University Medical Center Groningen, the Netherlands

Trial

STRONG-AF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:39

Hypertonic saline not effective in ambulatory patients with heart failure?

Presented By

Dr Marta Cobo Marcos, Iron Gate Majadahonda University Hospital, Spain

Trial

Phase 3, SALT-HF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:35

No effect of low-dose carperitide on mortality or hospitalisation in acute HF

Presented By

Dr Toshiyuki Nagai, Hokkaido University, Japan

Trial

LASCAR-AHF

Conference

HFA 2024

Type

Peer-reviewed article

16 July 2024 15:32

Meet the Trialist: Innovating cardiac monitoring with MONITOR-HF

Expert

Dr Jasper Brugts, Erasmus University Medical Center, the Netherlands

Trial

MONITOR-HF

Conference

HFA 2024

22 May 2024 15:19

SGLT2 inhibition in heart failure more advantageous for women than men

Presented By

Dr Mounica Vorla, University of Louisville School of Medicine, USA

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 14:00

Interatrial shunt for HF: neutral primary endpoint but potential benefit in HFrEF

Presented By

Prof. Gregg Stone, Icahn School of Medicine at Mount Sinai, NY, USA

Trial

RELIEVE-HF

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:45

STEP-HFpEF DM: Semaglutide beneficial in patients with HFpEF and diabetes

Presented By

Prof. Mikhail Kosiborod, Saint Luke's Mid America Heart Institute, MO, USA

Trial

Phase 3, STEP-HFpEF DM

Conference

ACC 2024

Type

Peer-reviewed article

16 May 2024 13:20

Meet the Trialist: The “Sweet Spot” from RELIEVE-HF

Expert

Prof.Gregg Stone

Trial

RELIEVE-HF

Conference

ACC 2024

15 May 2024 15:40

Can a walking intervention improve functional status and quality of life in HFrEF?

Presented By

Dr Tomas Vetrovsky, Charles University, Czechia

Trial

WATCHFUL

Conference

AHA 2023

Type

Peer-reviewed article

29 January 2024 15:30

Traditional Chinese medicine successful in HFrEF

Presented By

Dr Xinli Li, First Affiliated Hospital of Nanjing Medical University, China

Trial

Phase 4, QUEST

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:09

CRT upgrade benefits patients with HFrEF and an ICD

Presented By

Dr Béla Merkely, Semmelweis University, Hungary

Trial

BUDAPEST CRT Upgrade

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:08

Catheter ablation saves lives in end-stage HF with AF

Presented By

Prof. Christian Sohns, Heart and Diabetes Center NRW, Germany

Trial

CASTLE-HTx

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:07

Meta-analysis: Does FCM improve clinical outcomes in HF?

Presented By

Prof. Piotr Ponikowski, Medical University Wroclaw, Poland

Trial

CONFIRM-HF; AFFIRM-AHF; HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:06

HEART-FID: Is intravenous ferric carboxymaltose helpful in HFrEF with iron deficiency?

Presented By

Dr Robert Mentz, Duke University, USA

Trial

Phase 3, HEART-FID

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

Heart failure: the 2023 update

Presented By

Prof. Theresa McDonagh; Prof. Roy Stuart Gardner; Prof. Alexandre Mebazaa; Prof. Ewa Jankowska; Prof. Marianna Adamo

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:05

Natriuresis-guided diuretic therapy to facilitate decongestion in acute HF

Presented By

Dr Jozine ter Maaten, University of Groningen, the Netherlands

Trial

PUSH-AHF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:04

DICTATE-AHF: Early dapagliflozin to manage acute HF

Presented By

Prof. Zachary Cox, Lipscomb University College of Pharmacy, USA

Trial

Phase 3, DICTATE-AHF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:03

Cardiovascular disease and diabetes: new guidelines

Presented By

Prof. Emanuele Di Angelantonio; Prof. Nikolaus Marx; Dr Katharina Schuett; Prof. Dirk Müller-Wieland; Prof. Bianca Rocca

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:02

STEP-HFpEF: Semaglutide safe and efficacious in HFpEF plus obesity

Presented By

Dr Mikhail Kosiborod, University of Missouri, USA

Trial

Phase 3, STEP-HFpEF

Conference

ESC 2023

Type

Peer-reviewed article

30 October 2023 16:01

Standardised diuretic protocol significantly increases natriuresis in acute HF

Presented By

Dr Jeroen Dauw, AZ Sint-Lucas, Belgium

Trial

Phase 2, ENACT-HF

Conference

HFA 2023

Type

Peer-reviewed article

8 August 2023 16:04

Does adaptive pacing work in patients with HF, LBBB, and intact AV conduction?

Presented By

Dr Bruce Wilkoff, Cleveland Clinic, OH, USA

Trial

AdaptResponse

Conference

EHRA 2023

Type

News article

3 May 2023 16:04

ANTWERP score selects HF patients for AF ablation

Presented By

Dr Marco Bergonti, Cardiocentro Ticino Institute, Switzerland

Trial

ANTWOORD II

Conference

EHRA 2023

Type

News article

3 May 2023 15:29

Torsemide not superior to furosemide after hospitalisation for heart failure

Presented By

Prof. Robert Mentz, Duke University Hospital, NC, USA

Trial

Phase 3, TRANSFORM-HF

Conference

AHA 2022

11 January 2023 18:23

IRONMAN failed primary endpoint but shows potential long-term benefits of iron repletion in HF patients

Presented By

Prof. Paul Kalra, University of Glasgow, UK

Trial

Phase 4, IRONMAN

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 18:05

Up-titration of HF therapies following HF discharge saves lives

Presented By

Prof. Alexandre Mebazaa, Université Paris Cité, France

Trial

STRONG-HF

Conference

AHA 2022

Type

Peer-reviewed article

11 January 2023 17:57

New analysis assesses the safety of tofacitinib regarding extended MACE

Presented By

Prof. Maya Buch, University of Manchester, United Kingdom

Trial

ORAL Surveillance

Conference

ACR 2022

Type

News article

1 December 2022 14:18

AHA 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AHA 2022

28 November 2022 13:03

ESC 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

ESC 2022

15 September 2022 10:39

GALACTIC-HF: Omecamtiv mecarbil as option for HFrEF patients with low SBP

Presented By

Prof. Marco Metra, University of Brescia, Italy

Trial

Phase 3, GALACTIC-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 12:19

Patiromer helps HFrEF patients to optimise RAAS inhibitors without hyperkalaemia

Presented By

Prof. Stefan Anker, Charité Campus Virchow Clinic Berlin, Germany & Dr Javed Butler, Baylor University Medical Center, TX, USA

Trial

Phase 3, DIAMOND

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 12:13

DAPA-VO2: Rapid effect of dapagliflozin on peak VO2 in stable HFrEF

Presented By

Prof. Julio Núñez Villota , University of Valencia, Spain

Trial

Phase 4, DAPA-VO2

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 12:04

SERENADE: Macitentan fails in HFpEF plus PAH

Presented By

Prof. Adriaan Voors , University of Groningen, the Netherlands

Trial

Phase 2, SERENADE

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:49

Cardiac contractility modulation therapy promising for patients with HFpEF

Presented By

Prof. Cecilia Linde , Karolinska University Hospital, Sweden

Trial

CCM-HFpEF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:37

EMPULSE: Empagliflozin delivers rapid and clinically meaningful decongestion

Presented By

Prof. Piotr Ponikowski , Medical University of Wroclaw, Poland

Trial

Phase 3, EMPULSE

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:23

Dapagliflozin performs consistently across LVEF in HF

Presented By

Dr Mikhail Kosiborod , St. Luke’s Hospital, MO, USA

Trial

Phase 4, DEFINE-HF, PRESERVED-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 11:21

Cardiac wasting relevant for clinical outcomes in cancer

Presented By

Dr Alessia Lena , Charité Universitätsmedizin Berlin, Germany

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 10:45

Urocortin-2 a potential treatment target for HFpEF

Presented By

Ms Inês Vasconcelos, Medicine University of Porto, Portugal

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 10:43

Should ATTR-CM be added to the differential diagnosis of patients with HF?

Presented By

Dr Rocío Ruiz Hueso , University Hospital of Virgen Macarena, Spain

Trial

PREVAMIC

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 10:38

Delayed initiation of novel GDMTs associated with adverse outcomes in HF patients

Presented By

Prof. Gianluigi Savarese , Karolinska University Hospital, Sweden

Trial

EVOLUTION-HF

Conference

HFA 2022

Type

Peer-reviewed article

28 July 2022 10:36

DIAMOND trial: Patiromer lowers risk of severe hyperkalaemia

Presented By

Prof. Javed Butler, University of Mississippi, MS, USA

Trial

Phase 3, DIAMOND

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:12

Surprise outcome for SODIUM-HF

Presented By

Prof. Justin Ezekowitz, University of Alberta, Canada

Trial

Phase 3, SODIUM-HF

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 15:03

Sotagliflozin SCORED MACE benefit

Presented By

Prof. Deepak Bhatt, Brigham and Women's Hospital, USA

Trial

Phase 3, SCORED

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:57

Omecamtiv mecarbil does not impact exercise capacity of patients with HFrEF

Presented By

Prof. Michael Felker, Duke Clinical Research Institute, USA

Trial

Phase 3, METEORIC-HF

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 14:50

RCT-IVVE trial: Do HF patients benefit from annual flu shots?

Presented By

Prof. Mark Loeb, McMaster University, Canada

Trial

Phase 4, RCT-IVVE

Conference

ACC 2022

Type

Peer-reviewed article

15 June 2022 13:26

HFA 2022 Highlights Podcast

Presented By

Dr Robert van den Heuvel, Medicom

Conference

HFA 2022

13 June 2022 21:56

Benefits of SGLT2 inhibitors may extend beyond HF-associated outcomes

Presented By

Dr Ameenathul Fawzy, Liverpool Heart and Chest Hospital, UK

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 11:03

Left bundle branch area pacing is a feasible technique for HF and bradyarrhythmia

Presented By

Prof. Marek Jastrzębski, Jagiellonian University, Poland

Trial

MELOS

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:58

Focus on the efficacy of cardiac resynchronisation therapy in HF plus concomitant AF

Presented By

Dr Frederik Dalgaard, Herlev and Gentofte Hospital, Denmark

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:52

RESET: No survival benefit of CRT-defibrillator over CRT-pacemaker in heart failure

Presented By

Prof. Nikolaos Dagres, Heart Center Leipzig, Germany

Trial

RESET-CRT

Conference

EHRA 2022

Type

Peer-reviewed article

1 June 2022 09:46

ACC 2022 Highlights Podcast

Presented By

Dr Rachel Giles

Journal

Medicom

Conference

ACC 2022

20 April 2022 10:50

Reduction in atrial arrhythmias in patients with CIED on SGLT2 inhibitors

Expert

Prof. Ilan Goldenberg, University of Rochester, NY, USA

Trial

DAPA-HF

Conference

AHA 2021

3 February 2022 23:10

Empagliflozin efficacious in HF patients with preserved ejection fractions ≥50%

Presented By

Dr Stefan Anker, Charité University Berlin, Germany

Trial

EMPEROR-Preserved

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:15

EMPULSE: Empagliflozin improves outcomes of acute heart failure

Presented By

Prof. Adriaan Voors, University of Groningen, the Netherlands

Trial

Phase 3, EMPULSE

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 15:03

CHIEF-HF: Canagliflozin improves health status in heart failure

Presented By

Prof. John Spertus, University of Missouri-Kansas City, USA

Trial

Phase 3, CHIEF-HF

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:59

DREAM-HF: MPC therapy for HFrEF did not meet primary endpoint

Presented By

Dr Emerson Perin, Texas Heart Institute, US

Trial

Phase 3, DREAM-HF

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:52

Therapeutic approaches in heart failure with diabetes

Presented By

Prof. Lynne Stevenson, Vanderbilt University Medical Center, USA

Conference

AHA 2021

Type

Peer-reviewed article

14 January 2022 14:48

Valsartan seems to attenuate hypertrophic cardiomyopathy progression

Presented By

Prof. Carolyn Ho, Brigham and Women’s Hospital, USA

Trial

Phase 2, VANISH

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 14:41

Empagliflozin: First drug with clear benefit in HFpEF patients

Presented By

Prof. Stefan Anker, Charité University Hospital, Germany

Trial

Phase 3, EMPEROR-Preserved

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 13:45

CardioMEMS: neutral outcome but possible benefit prior to COVID-19

Presented By

Prof. JoAnn Lindenfeld, Vanderbilt University Medical Center, USA

Trial

GUIDE-HF

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 13:36

Antagonising the mineralocorticoid receptor beneficial for patients with diabetes and CKD

Presented By

Prof. Bertram Pitt, University of Michigan School of Medicine, USA

Trial

Phase 3, FIGARO-DKD

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:40

2021 ESC Guidelines on Heart Failure

Presented By

Prof. Carolyn Lam, Duke-NUS Medical School, Singapore

Conference

ESC 2021

Type

Peer-reviewed article

26 October 2021 12:34

ESC 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

EMPEROR-Preserved, ENVISAGE-TAVI, TOMAHAWK, FIGARO-DKD, FIDELITY, STEP, GUIDE-HF

Conference

ESC 2021

14 September 2021 20:32

Iron substitution improves LVEF in intensively treated CRT patients with iron deficiency

Presented By

Dr Pieter Martens, Hospital Oost-Limburg, Belgium

Trial

Phase 4, IRON-CRT

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 16:10

Novel mineralocorticoid receptor antagonist effective irrespective of HF history

Presented By

Prof. Gerasimos Filippatos, Attikon University Hospital, Greece

Trial

FIDELIO-DKD

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 16:05

Iron substitution in iron-deficient HF patients is highly cost-effective

Presented By

Prof. Phil McEwan, Swansea University, UK

Trial

AFFIRM-AHF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:59

Omecamtiv mecarbil might be less effective in patients with atrial fibrillation or flutter

Presented By

Prof. Scott Solomon, Brigham and Women’s Hospital, MA, USA

Trial

GALACTIC-HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:52

Vericiguat effective irrespective of atrial fibrillation status

Presented By

Prof. Piotr Ponikowski, Wrocław Medical University, Poland

Trial

VICTORIA

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:45

Baroreflex activation: a novel option to improve heart failure symptoms

Presented By

Prof. Andrew Coats, University of Warwick, UK

Trial

BEAT-HF; HOPE4HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:35

Beta-blocker withdrawal to enhance exercise capacity in heart failure?

Presented By

Prof. Julio Nuñez Villota, University Clinical Hospital of Valencia, Spain

Trial

Phase 4, PRESERVE-HR

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:29

Inconclusive results for dapagliflozin treatment in heart failure

Presented By

Prof. John McMurray, University of Glasgow, UK

Trial

DETERMINE-Reduced; DETERMINE-Preserved

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:23

Computerised cognitive training improves cognitive function in HF patients

Presented By

Sonja Wedegärtner, Saarland University Hospital, Germany

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 15:15

Real-world study suggests sacubitril/valsartan benefits elderly patients with HF

Presented By

Dr Andrea Herbst, Azienda Ospedaliero-Universitaria Careggi, Italy

Trial

PARADIGM-HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:59

Proenkephalin: A useful biomarker for new-onset heart failure?

Presented By

Dr Lisa Emmens, University Medical Center Groningen, the Netherlands

Trial

PREVEND

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:56

Weight loss associated with increased mortality risk in heart failure patients

Presented By

Dr Nuno Melo, Centro Hospitalar e Universitário de São João, Portugal

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:53

Echocardiographic parameters linked to dementia diagnosis

Presented By

Dr Karol Nowak, Jagiellonian University Medical College, Poland

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:49

Telemedicine: Every light has its shadow

Presented By

Dr Arvind Singhal, Royal Brompton Hospital, UK

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 12:46

COVID-19-related HF: from systemic infection to cardiac inflammation

Presented By

Prof. Marco Metra, University of Brescia, Italy

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:19

Increased COVID-19 mortality in patients with cardiorenal comorbidity

Presented By

Dr Johan Bodegård

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:07

Myocardial infarction outcomes were significantly affected by the pandemic

Presented By

Dr Ayman Haq, Baylor University Medical Center, USA

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 10:03

Empagliflozin linked to lower cardiovascular risk and renal events in real-world study

Presented By

Prof. Leo Niskanen, University of Eastern Finland, Finland

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:43

Efficacy of dapagliflozin and empagliflozin not influenced by diabetes status

Presented By

Prof. Faiez Zannad, University of Lorraine, France

Trial

EMPEROR-Reduced; DAPA=HF; DAPA-CKD; EMPA-Kideney

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:39

TAPSE effective biomarker associated with high-risk of severe COVID-19

Presented By

Dr Neil Bodagh, King´s College Hospital NHS Foundation Trust, UK

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:38

COVID-19 in AF patients with HF: no higher mortality but longer hospital stay

Presented By

Prof. Bektaş Murat, Eskisehir Osmangazi University, Turkey

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:38

Psychoactive substances put young people at risk of cardiovascular disease

Presented By

Dr Vijay Chopra, Max Super Speciality Hospital Saket, India

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:28

Heart failure patients might be at an increased risk for head and neck cancer

Presented By

Dr Mark Luedde, Christians-Albrechts-University of Kiel, Germany

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:21

The challenge of improving the quality of life of heart failure patients

Presented By

Prof. Ileana L. Piña, Central Michigan University, USA

Trial

DAPA-HF; PROVE-HF

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:20

Trastuzumab associated with cardiotoxicity in breast cancer

Presented By

Dr Ana Filipa Cardoso, Hospital Senhora da Oliveira-Guimarães, Portugal

Conference

HFA 2021

Type

Peer-reviewed article

19 August 2021 09:18

PARADISE-MI: Sacubitril/valsartan not superior to ramipril in reducing HF events

Presented By

Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA

Trial

Phase 3, PARADISE-MI

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 23:29

Older adults with heart failure benefit from rehabilitation programme

Presented By

Dr Dalane Kitzman , Wake Forest School of Medicine, NC, USA

Trial

REHAB-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 21:42

Quality improvement intervention fails to improve care for patients with heart failure

Presented By

Prof. Adam DeVore, Duke University School of Medicine, USA

Trial

CONNECT-HF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 20:54

Sacubitril/valsartan does not reduce NT-proBNP versus valsartan alone in HFrEF

Presented By

Prof. Douglas Mann, Washington School of Medicine, USA

Trial

Phase 4, LIFE

Conference

ACC 2021

9 July 2021 19:02

Ablation-based rhythm control as effective as rate control in AF and HF

Presented By

Prof. Anthony Tang, University of Ottawa, Canada

Trial

RAFT-AF

Conference

ACC 2021

Type

Peer-reviewed article

9 July 2021 14:41

RACE 3 long-term results show fading benefit of targeted therapies in AF and HF

Presented By

Prof. Michiel Rienstra, University Medical Center Groningen, the Netherlands

Trial

RACE 3

Conference

EHRA 2021

Type

Peer-reviewed article

16 June 2021 13:07

Omecamtiv mecarbil improves outcomes in HFrEF-patients

Presented By

Prof. John Teerlink, University of California, San Francisco, USA

Trial

GALACTIC-HF

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:25

IV iron reduces HF hospitalisation

Presented By

Prof. Piotr Ponikowski, Wroclaw Medical University, Poland

Trial

AFFIRM-AHF

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:22

Dapagliflozin reduces renal risk independent of CV disease status

Presented By

Prof. John McMurray, University of Glasgow, Scotland

Trial

DAPA-CKD

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:18

“Strongly consider an SGLT2-inhibitor in most T2DM patients”

Presented By

Prof. Deepak Bhatt, Brigham and Women’s Hospital, USA

Trial

Phase 3, SOLOIST-WHF; SCORED

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:14

Additional HFrEF education and patient-engagement tools

Presented By

Prof. Larry Allen, University of Colorado School of Medicine, USA

Trial

EPIC-HF

Conference

AHA 2020

Type

Peer-reviewed article

18 February 2021 10:09

High-dose influenza vaccine in patients with CVD

Presented By

Prof. Orly Vardeny, University of Minnesota Medical School, USA

Trial

Phase 4, INVESTED

Conference

AHA 2020

Type

Peer-reviewed article

17 February 2021 10:36

SGLT2 inhibitor improves cardiovascular outcomes in heart failure patients

Presented By

Dr Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, EMPEROR-Reduced trial

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:40

Reduced NT-proBNP in HFpEF with sacubitril/valsartan

Presented By

Prof. Burkert Pieske, Charité University Medicine Berlin, Germany

Trial

Phase 3, PARALLAX study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:26

Antihypertensives also reduce CV risk in people with normal blood pressure

Presented By

Prof. Kazem Rahimi, University of Oxford, UK

Trial

BPLTTC study

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 13:14

SGLT2 inhibitor ertugliflozin shows similar mortality but fewer HF hospitalisations

Presented By

Prof. Francesco Cosentino, Karolinska University Hospital, Sweden

Trial

VERTIS CV

Conference

ESC 2020

Type

Peer-reviewed article

5 November 2020 12:39

Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy

Presented By

Dr Carolyn Y. Ho, Brigham and Women's Hospital, USA

Trial

Phase 2, MAVERICK-HCM

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 17:57

Vericiguat shows beneficial effects in a very high-risk HF population

Presented By

Prof. Paul Armstrong, University of Alberta, Canada

Trial

Phase 3, Victoria

Conference

ACC 2020

Type

Peer-reviewed article

7 September 2020 17:48

DAPA-HF: Dapagliflozin also good for heart failure patients without diabetes, of any age, or any health status

Presented By

Prof. John J. McMurray & Prof. Felipe A. Martinez

Trial

Phase 3, DAPA-HF

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 19:16

PARAGON-HF: Benefits for women and lower ejection fraction

Expert

Prof. Scott D. Solomon & Prof. Lynne W. Stevenson

Trial

PARAGON-HF

Conference

AHA 2019

Type

Peer-reviewed article

26 February 2020 15:19

No benefit of percutaneous reduction of secondary mitral regurgitation in HF patients over standard care

Expert

Prof. Jean-Francois Obadia, Civil Hospices of Lyon, France

Trial

MITRA-FR

Conference

ESC 2019

Type

Peer-reviewed article

10 October 2019 08:49

Frequent use of beta-blocker after HFpEF hospitalisations in elderly patients without compelling indications

Presented By

Dr Brian Yum, Weill Cornell Medicine, USA

Trial

Cohort study, REGARDS

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 13:07

High 5-year survival rates for older HF patients without initial severe comorbidity

Presented By

Dr Christian Madelaire, University of Copenhagen Herlev Hospital, Denmark

Conference

ACC 2019

Type

Peer-reviewed article

6 June 2019 11:13

DECLARE TIMI-58 trial shows benefits of dapagliflozin in high-risk subgroups

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 14:16

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 13:30

2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

Conference

ACC 2019

Type

Peer-reviewed article

4 June 2019 11:58